Investing.com - Financial Markets Worldwide
🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

London stocks set for weekly loss; Indivior jumps

Published 15/01/2021, 09:24
© Reuters.
UK100
-
MGGT
-
FTNMX501010
-
FTNMX551030
-
INDV
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE 100 down 0.5%, FTSE 250 off 0.2%

Jan 15 (Reuters) - British shares dropped on Friday and were
set to close the week lower as fresh lockdowns and rising virus
cases dampened hopes of a swift economic recovery, while
drugmaker Indivior gained on higher revenue forecast.
The British economy will take more than two years to recover
to its pre-coronavirus level, a Reuters poll found, with more
than 70 economists saying it would contract 1.4% this
quarter. The blue-chip FTSE 100 index .FTSE fell 0.5%, with mining
.FTNMX1770 and construction stocks .FTNMX2350 declining the
most.
The UK economy shrank by 2.6% in November, its first monthly
fall in output since the depths of an initial COVID-19 lockdown
in April, as new movement restrictions were imposed, but the
drop was much lower than the average forecast. Aircraft parts supplier Meggitt MGGT.L gained 3.0% after
it said the recent launch of COVID-19 vaccines and pent-up
demand could support a recovery in civil aviation this
year. Indivior Plc INDV.L gained 6.2% after raising its annual
revenue forecast, while AstraZeneca slipped 0.3% even after its
cancer drug Imfinzi received approvals in Europe and
Britain.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.